Skip to main content

Penny Stocks in the Spotlight: Watchlist Essentials (EPAZ, HMBL, CLNV, NHMD)

The penny stock space attracts a lot of attention from investors due to the sort of gains those stocks can generate in a short span of time. Here is a look at four penny stocks that have hit the radar of investors recently.

Epazz Inc. (OTC: EPAZ): The cloud-based software leader is a specialist in providing made-to-order cloud applications to corporations, public sector entities, and institutions of higher learning. Epazz Inc. also offers Epazz BoxesOS V3.0, which is described as a comprehensive web-based business software package for small to mid-sized businesses, governmental agencies, Fortune 500 companies, and higher education institutions.

On October 3, the company announced that its holding company, ZenaDrone, would send its first drones to Ireland. The drones had been at its new manufacturing plant. The shipment would comprise the first set of 20 ZenaDrone 1000s, which would help in the establishment of drone as a service (DaaS) operations in Ireland.

In the news release, the company noted that each deployed drone could generate more than $100,000 a year in revenues. ZenaDrone would collaborate with Irish farmers to monitor spray weeds and plant health. Additionally, the drones would also be integrated into the first responder system and used by the fire departments as well as the police force.

Epazz had announced on September 26 that ZenaDrone had formed a German corporation named ZenaDrone GmbH for the purpose of demonstrating its wares in Germany and other NATO nations. The formation of the new corporation had been important in the conversion of leads from the AERO trade share in Germany into actual demonstrations. The new corporation had been formed since the German authorities needed a German entity to be registered with the German Aviation Authority. The strategic step would allow ZenaDrone to move into the growing European market and create a solid presence there.

HUMBL Inc. (OTC: HMBL) The technology company, which is involved in a range of niches, announced the launch of the HUMBL Pro+ subscription service on September 28. In its news release, HUMBL Inc. announced that subscribers would be offered a range of benefits as part of the new suite of services.

The company noted that the benefits would help the user to graduate to Web3 from Web2 through the deployment of search, digital wallets, verified profiles, monetization, and advertising solutions. Subscribers would also be provided with early access to new features, discounts on ads, social media post editing, unlimited artificial intelligence-powered chat, priority customer support, a customizable pro page, the opportunity to become a featured user, and extra points for community building. It will also allow customers to tailor how they appear in search results. The company rolled out the service at the initial price of $7.99 a month, billed on a yearly basis.

Clean Vision Corporation (OTC: CLNV), the emerging sustainable clean technology developer, announced on September 7 that the sum of $1.75 million in the form of a forgivable loan had been disbursed to it. It was pertaining to a Memorandum of Agreement between Clean Vision Corporation and the West Virginia Department of Economic Development that had been signed in June 2023.

As per the provisions of the agreement, the company would have to employ at least 40 people for the loan to be forgiven. In the news release, Clean Vision noted that the fresh funding was non-dilutive in nature and would help in speeding up the launch of its path breaking plastic waste to circular fuel plant located in Quincy, Virginia. The company’s subsidiary unit, Clean Seas West Virginia Inc., would be involved in the development of the project and address plastic pollution, one of the biggest environmental challenges globally at this point.

GlobeStar Therapeutics Corporation (OTC: GSTC) is a clinical-stage pharmaceutical company involved in the development of therapies for multiple sclerosis (MS) and other neurological diseases. On September 28, the company announced that it had entered into a definitive agreement with SMI HealthCare LLC.

As per the terms of the agreement, SMI would be responsible for managing the initial clinical trial, intellectual property filings, sales, manufacturing, and distribution of GlobeStar’s MS treatment in Africa, India, Southeast Asia, and the Middle East, barring Iraq and Israel. The company is the exclusive global licensee of Project Amethyst, inclusive of all patents and patent applications. India is now one of the preferred global locations for high-level clinical trials because the cost is around 50% of the expenses of similar trials in the United States. Due to the priority for MS-related products in India, it could also be the right time to launch MS trials in the country.

Nate's Food Co. (OTC: NHMD): On October 3, the company was in the news after it announced that it had hit a major new milestone as a business. It announced that it had been successful in canceling as many as 1 billion shares, which resulted in the reduction of its issued and outstanding shares by as much as 27%. It ought to be noted that the move had been authorized by the officers and directors of the company and had also been revealed in an 8-K filing with the United States Securities and Exchange Commission.

The significant move was part of the company’s overall strategy and was also closely linked to Nate’s Food’s upcoming acquisition of JP Energy Partners. In the news release, the company went on to add that it wanted to provide long-term value to its shareholders. It went on to add that the cancellation of 1 billion shares was a demonstration of that commitment.



Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.